FDA Inspection 1256302 — MYLAN LABORATORIES LTD
The FDA completed an inspection of MYLAN LABORATORIES LTD on Nov 22, 2024 in Bengaluru. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 22, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bengaluru (India)
Additional Details
Bioanalytical BA/BE